Podcast Summary: CNBC's Fast Money
Episode: "Mag7 Results On Deck… And The Non-U.S. Equity Trade"
Date: January 23, 2026
Host: Melissa Lee
Panelists: Tim Seymour, Steve Grasso, Fanwood Ice (Bonawyn Eison), Mike Koh
Special Guests: Paul Walsh (G2 Weather Intelligence), Peter Zaitsev (Luxury Real Estate Broker)
Overview
This episode of Fast Money dives into the pivotal upcoming earnings week for the "Mag 7" mega-cap tech stocks, explores the outlook for non-U.S. equities, and touches on diverse market-moving topics including a massive winter storm, surges in gold and silver, the state of the small-cap rally, drama in chip stocks, notable moves in luxury real estate, and what to watch in non-tech earnings. Throughout, the panel shares actionable trading insights and assesses sentiment drivers for the week ahead.
1. Mega-Cap Tech Earnings: The Mag 7 in Focus
(Starts at 00:47)
Main Points
- Four of the "Mag 7"—Meta, Microsoft, Tesla, and Apple—are set to report earnings.
- After underperforming so far in 2026, Mag 7 names saw a rebound this week, with Meta up 6%; Apple lagged, down nearly 3% (00:47).
- Discussion centered on whether these names can regain their momentum and which stocks have the most to prove.
Key Panel Insights
-
Microsoft—Expectations and Risks
- Tim Seymour (02:11):
"Today kind of felt like the day that MAGA fought back... Microsoft has been the biggest disappointment to me both on the charts but really ultimately in terms of where I think expectations were... The valuation is back to a place where people can own it. I don't think this thing's going to get away from you."
- Fanwood Ice (Bonawyn Eison, 04:42):
"Microsoft still has a significant flywheel... Capex will come under scrutiny and Azure growth is the key to watch... But I think a lot of the AI tailwind has somewhat been taken out in the last 3-6 months."
- Tim Seymour (02:11):
-
Valuation Shifts—Rotation into Small Caps
- Steve Grasso (03:28, 04:01):
"Russell valuation trades at around 15 times. Mag 7 trades around 30 times, 35 times. I think they're gonna take a look and maybe go with the Russell."
- Steve Grasso (03:28, 04:01):
-
Meta—Sentiment and Spending Concerns
-
Mike Koh (06:03):
"Of all four, the options market seems least certain about Meta and is expecting the biggest moves—more than 6%... But Apple and Tesla also have dubious sentiment." -
Tim Seymour (07:11):
"Do you want to see capex cuts? ... Anything that signals a little less capex [at Meta] could give the stock a shot in the arm." -
Fanwood Ice (08:28):
"Meta is the cheapest in the group... It seems like weakness in sector-wide ad traffic ends up being more concentrated within Meta—so it can be a port within the storm." -
Steve Grasso (09:28): "We haven't even discussed TikTok. That's probably the biggest headwind for Meta."
-
-
Apple—Dubious AI Prospects
- Melissa Lee (06:57):
"Apple—we're not expecting them to show any sort of proof of AI in their earnings... that's why Apple has been dubious for a long time."
- Melissa Lee (06:57):
-
Earnings Playbook Wrap-up
- Panel generally likes Microsoft on valuation, sees risk in heavy Meta spending, and identifies Apple as a safer, defensive play ahead of earnings.
2. Small Cap Pullback and Sector Rotation
(03:28, 04:01, 28:28)
- The Russell 2000 reversed its 2026 outperformance, but valuation spreads mean investors may start favoring small caps over expensive mega caps.
- Panel agrees that some mean reversion after large cap underperformance is possible.
3. Intel’s Post-Earnings Rout
(20:56)
Main Points
- Intel stock plunged 17% following soft guidance and supply shortage warnings.
- Tim Seymour: "I covered calls... ultimately there was never a valuation argument for Intel. Even at its low levels, there has been this strategic element... I think Intel meanders here." (21:24)
- Fanwood Ice: "Still an early innings turnaround story, not an AI story... flat to negative EPS. The recent price action isn't justified." (22:20)
- Steve Grasso: "It's become a meme stock... could come back into that $40-ish level. It's a supply side issue, not a demand side issue. I’d still be a buyer." (23:18)
4. Massive Winter Storm—Retail and Restaurants at Risk
(12:03)
Paul Walsh (G2 Weather Intelligence) Interview
-
The upcoming storm is described as a "winter hurricane," with expected shutdowns across the South and Northeast.
-
Retail and restaurant businesses expected to see sharp Q4 sales impacts, with home improvement and groceries facing pre-storm surges followed by shutdowns.
-
Quote: "Grocers here in the western suburbs of Philadelphia are already running out of inventory... it's going to take really good execution by these retailers." (13:41)
-
Walsh expects possible negative retail earnings surprises next month.
-
Tim Seymour follow-up: "Why wasn't a mild winter a tailwind? Why can't we look past this?" (15:04)
-
Walsh: Retailers did benefit from a cold Q3 that likely pulled forward demand; Q4 could see negative surprises as a result of this storm on top of already weak traffic. (15:47)
5. Gold & Silver at Record Highs—A Geopolitical, Not Just Economic, Trade
(28:28, 31:28)
- Gold closed just shy of $5,000/oz., silver above $100—historical firsts.
- Global reserve diversifiers (China, Russia, India) are driving demand, not just retail.
- Tim Seymour: "Gold’s got ahead of itself short term... be careful here, I think we’ll see 4600 before we see 5100... every money manager is wondering do we have enough gold?" (31:28)
- Steve Grasso: "Silver is the only one you could actually [justify on supply-demand]... if you’re looking for a reason to buy it at these levels other than emotion, silver is probably the metal." (32:47)
- Substitution: Indian buyers switching from gold to silver due to high price (33:23).
- Mike Koh: Heavily traded options suggest exuberance, looking for a potential downside reversal (33:50).
- Fanwood Ice: Rotations into hard assets and geopolitics are in focus, but extreme moves “fly under the radar.” (34:42)
6. Novo Nordisk’s WeGovy Pill—A Transformative Launch?
(26:13)
- Prescription data for Novo’s oral GLP-1 "WeGovy" pill: >18,000 scripts week 2 (vs. 4,300 week 1); may be even higher excluding DTC channel sales.
- Tim Seymour: "The stock was oversold... [pill launch] is a very important strategic move, but not necessarily a structural change in the business… I think it goes higher." (26:45)
- Panel discusses potential cannibalization of injectable sales, slightly lower margins on pills, but broader patient adoption offsetting margin hit.
- Steve Grasso: "50% of people who could take a GLP-1 don't because they're afraid of needles... they'll take the oral. Less margin, but made up in volume." (28:14)
- Fanwood Ice: Pill reduces supply-chain pressure; 'defending turf' keeps market share from Eli Lilly. “A two-man race [with Lilly] is kind of supported by this data.” (29:05)
7. U.S. Real Estate: Manhattan Luxury Market Defies Tax Fears
(36:16)
Peter Zaitsev Interview (Luxury Broker, Owning Manhattan, Netflix)
- NYC luxury ($4M+) market hit new records post-"Mamdani" (progressive taxation) proposals; trophy sales surging and rentals at highs.
- Peter Zaitsev: “Trophy apartments are selling at record numbers… Rental numbers are through the roof… I haven’t seen New York this busy in my lifetime.” (36:22)
- Despite political risks, the super-wealthy are not deterred; tax changes have not impacted demand for high-end properties.
- Limited future supply: "If you’re not buying in the next 6-12 months, you’re not going to be able to buy because there’s no inventory." (39:43)
- Foreign buyer activity focused on Asian wealth flows into NYC.
- Top amenities for luxury: cold plunges and saunas post-pandemic.
- Zaitsev: “Health and wellness have played really big after COVID.” (41:00)
8. Non-Tech Earnings Preview: Focus on Boeing, UPS, GM, Starbucks
(42:06)
- Panel highlights key non-tech names reporting next week.
- Steve Grasso: Watching Boeing as a defense barometer: "Been long a smidge below 200... every time you hear buildup in defense, it still has a little more room to run." (42:10)
- Tim Seymour: Likes both UPS and GM; sees transformation in GM and a trough passed in UPS. (43:41)
- Mike Koh: Starbucks options market pricing an 8% move—higher than usual (44:20). Large options traders betting on a contained move, implying less dramatic post-earnings volatility.
- Steve Grasso: Bullish on new CEO’s progress at Starbucks. (45:40)
Notable Quotes & Moments
-
On Mega Cap Tech:
Tim Seymour, 02:11:"I just think [Microsoft] is the one that has been the biggest disappointment to me... the valuation is back to a place where people can own it."
-
Meta’s Ad Risks:
Fanwood Ice, 08:28:"Meta ends up taking more share of what might be a slightly shrinking pot [of ad revenue]."
-
On Intel’s Volatility:
Steve Grasso, 23:18:"It's become a meme stock."
-
Gold’s Surge:
Tim Seymour, 31:28:"Be careful here... I think we’ll see 4600 before we see 5100 [in gold]."
-
NYC Real Estate:
Peter Zaitsev, 36:22:"Trophy apartments are selling, and they’re selling at record numbers… I haven’t seen New York this busy in my lifetime."
-
On WeGovy Pill:
Steve Grasso, 28:14:"50% of people who could take a GLP-1 don't want to [because] they're afraid of needles... they're going to take the oral [pill]."
Timestamps for Key Segments
- Mag 7 Earnings Setup: 00:47 – 12:03
- Intel Earnings Fallout: 20:56 – 23:45
- Winter Storm & Retail Impact: 12:03 – 17:27
- Gold/Silver Rally: 28:28 – 35:27
- Novo Nordisk's WeGovy Pill: 26:13 – 30:01
- NYC Luxury Real Estate Market: 36:16 – 41:19
- Non-Tech Earnings Preview: 42:06 – 46:01
Final Trades
(46:14)
- Mike Koh: Vistra (VST) is attractively valued; start adding around $150.
- Tim Seymour: Selling calls in GDX (gold miners ETF), being tactical—gold’s short-term run is overdone.
- Fanwood Ice: Highest quality way to own air infrastructure with real earnings/free cash flow.
- Steve Grasso: Microsoft; "Be careful with the storm... go with [MSFT]."
Conclusion
The panel expects next week's earnings—especially from big tech—to set the tone for Q1. With shifting sector leadership, global market crosswinds, and unexpected events (weather, geopolitics, regulation), the need for agility and selective stock picking is front-and-center. Dominant themes include the durability (or fragility) of mega-cap growth, the gravity of non-U.S. reserve diversification, and the resilience of specific sectors like luxury real estate and weight-loss pharmaceuticals.
For investors seeking actionable ideas and a clear road map into a news-heavy week, this episode is a rich source of context and trading strategies.
